ADR Reporting Statement: Seek medical attention immediately at the first sign of any adverse drug reaction.
FC tablet: Bleeding complications related to hypoprothrombinaemia and/or platelet dysfunctions have occurred especially with cephalosporins and cephamycins having a N-methylthiotetrazole side-chain, including cefamandole, and latamoxef. The presence of a methylthiadiazolethiol side-chain, as in cefazolin, or a N-methylthiotriazine ring, as ceftriaxone, might also be associated with such bleeding disorders.
Oral Suspension: Bleeding complications related to hypoprothrombinaemia and/or platelet dysfunctions have occurred especially with cephalosporins and cephamycins having a N-methylthiotetrazole side chain, including cefamandole, cefbuperazone, cefmenoxime, cefmerazole, cefonicid, cefoperazone, cefotetan, cefpiramide, and latamoxef. The presence of a methylthiadiazolethiol side chain, as in cefazolin, or a N-methylthiotriazine ring, in ceftriaxone, might also be associated with such bleeding disorders.
View ADR Monitoring Form